Skip to content
The Policy VaultThe Policy Vault

Androgel 1.62%CareFirst (Caremark)

Delayed puberty

Initial criteria

  • Requested drug is NOT being prescribed for age-related hypogonadism (also referred to as late-onset hypogonadism)
  • Request is for intramuscular testosterone enanthate injection (generic Delatestryl) OR testosterone propionate implant pellet (Testopel)

Reauthorization criteria

  • All continuation of therapy requests must meet all requirements in the coverage criteria section

Approval duration

36 months